| Abstract: |
This disclosure teaches phospholipid nanoparticle compositions of cannabinoids formed from phospholipids and simpler lipids in an unfired sequential process that encapsulate a high concentration of cannabinoids, and create standardized precision-metered dosage forms of cannabinoids; yielding an increase cannabinoid transport across hydrophobic mucosa; increase the bioavailability of the cannabinoid 2-fold to 8-fold, decrease the dose of cannabinoids 2-fold to 8-fold less than an amount of cannabinoids needed to illicit the same therapeutic effect compared to raw and non-encapsulated cannabinoids; where the nanoparticle dynamic structure reduces the adverse effects of cannabinoids; and enable safe more efficacious cannabinoid therapy. |
| Inventor: |
Kaufman, Richard Clark (Santa Monica, CA, US) |
| Applicant: |
NanoSphere Health Sciences, LLC (Kelowna, CA) |
| Face Assignee: |
N/A |
| Filed: |
2020-03-23 |
| Issued: |
2020-07-30 |
| Claims: |
13 |
|
US20200237679
|
1. A drug delivery system comprising nanoparticle structures; wherein a single layer of essential phospholipids encapsulates liquid lipids and drug in each nanoparticle structure;
(10)
(3)
|
|
12. A method of drug therapy comprising treatment with the drug; wherein the drug is encapsulated in nanoparticle structures; wherein a single layer of essential phospholipids encapsulate liquid lipids and drug; wherein the nanoparticle structure has a particle size distribution from 50 to 150 nm; and wherein the nanoparticle structure yields standardized precision-metered dose drug.
(1)
(0)
|
|
